BCR-ABL1-like ALL
In this podcast, Dr. Rijneveld discusses BCR-ABL1-like acute lymphoblastic leukemia (ALL), a specific subgroup of ALL characterized by an expression profile similar to Ph+ ALL, albeit lacking the BCR-ABL1 rearrangement, and by sensitivity to TKIs. She highlights how TKIs were game-changing for the prognostic of these patients, although their cost and associated toxicities (usually low but fatiguing in the long-term), may still be issues in the clinical practice.
Interview with: Anita Rijneveld. Host: Shaun McCann
What did you think of this podcast? Share your opinions with us in this short…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.